Why the study?
Does the TAPSE/sPAP ratio help identify patients with pulmonary vascular disease due to chronic thromboembolism and predict impaired pulmonary exercise haemodynamics?
Does the TAPSE/sPAP ratio help identify patients with pulmonary vascular disease due to chronic thromboembolism and predict impaired pulmonary exercise haemodynamics?
The TAPSE/sPAP ratio serves as a simple, non-invasive surrogate of RV-PA coupling that can identify PVD in chronic thromboembolism and predict impaired exercise hemodynamics.
Answers are grounded in this paper and cite their sources.
May support noninvasive RV–PA coupling assessment in chronic thromboembolic PVD; hypothesis-generating and requires prospective validation.
This retrospective study shows that TAPSE/sPAP ratio, a simple surrogate of RV–PA coupling, may help to identify patients with PVD due to chronic thromboembolism and predicts impaired pulmonary exercise haemodynamicshttps://bit.ly/3osXxzV
No takes yet. Share an insight, caveat, or question.
Douschan et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: